TABLE 3.
Variables | Univariable analysis |
Multivariable analysis |
||
Odds ratio (95% CI) | P-value | Odds ratio (95% CI) | P-value | |
Loss of finger pad | 1.911(1.004−3.636) | 0.049 | ||
Sclerodactyly | 1.750(1.029−2.977) | 0.039 | ||
Muscle involvement | 2.375(1.078−5.233) | 0.032 | 2.551(1.054−6.175) | 0.038 |
LVDD | 2.054(1.208−3.490) | 0.008 | 2.360(1.277−4.361) | 0.006 |
PAH | 5.612(1.596−19.731) | 0.007 | 9.134(2.335−35.730) | 0.001 |
dcSSc | 2.754(1.543−4.914) | 0.001 | 2.859(1.489−5.487) | 0.002 |
NLR | 1.155(1.017−1.312) | 0.027 | ||
PLR | 1.005(1.001−1.008) | 0.008 | 1.005(1.001−1.008) | 0.020 |
Elevated ferritin | 2.371(1.207−4.656) | 0.012 | ||
Elevated KL-6 | 2.103(1.227−3.604) | 0.007 | 2.033(1.099−3.763) | 0.024 |
Anti-Scl-70 | 2.129(1.232−3.679) | 0.007 | 3.101(1.647−5.840) | < 0.001 |
ACA | 0.476(0.259−0.875) | 0.017 |
*All variables with a p-value below 0.05 from the univariable analysis were entered in multivariable analysis (forward logistic regression). SSc, systemic sclerosis; ILD, interstitial lung disease; LVDD, left ventricular diastolic dysfunction; dcSSc, diffuse cutaneous systemic sclerosis; NLR, neutrophil to lymphocyte ratio; PLR, platelet to lymphocyte ratio; KL-6, Krebs von den Lungen-6; anti-Scl-70, anti-scleroderma-70; ACA, anti-centromere antibody. Bold values indicate P < 0.05.